Details for Patent: 6,956,027
Summary for Patent: 6,956,027
| Title: | N-terminally chemically modified protein compositions and methods |
| Abstract: | Provided herein are methods and compositions relating to the attachment of water soluble polymers to proteins. Provided are novel methods for N-terminally modifying proteins or analogs thereof, and resultant compositions, including novel chemically modified G-CSF compositions and related methods of preparation. |
| Inventor(s): | Olaf B. Kinstler |
| Assignee: | Amgen Inc |
| Application Number: | US10/264,846 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 6,956,027
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,956,027
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0733067 | ⤷ Start Trial | SPC033/2002 | Ireland | ⤷ Start Trial |
| European Patent Office | 0733067 | ⤷ Start Trial | 91006 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 0733067 | ⤷ Start Trial | CA 2003 00002 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
